177 related articles for article (PubMed ID: 30317357)
1. Xeroderma Pigmentosum - Cockayne Syndrome Complex (XP-CS) - Another case.
Metlo A; Rehan A; Akmal M; Iqbal U; Jamali M
J Pak Med Assoc; 2018 Oct; 68(10):1531-1534. PubMed ID: 30317357
[TBL] [Abstract][Full Text] [Related]
2. Xeroderma pigmentosum-Cockayne syndrome complex.
Natale V; Raquer H
Orphanet J Rare Dis; 2017 Apr; 12(1):65. PubMed ID: 28376890
[TBL] [Abstract][Full Text] [Related]
3. [Ocular manifestations in xeroderma pigmentosum].
Süsskind D; Berneburg M; Rohrbach JM
Klin Monbl Augenheilkd; 2011 Mar; 228(3):239-44. PubMed ID: 20799158
[TBL] [Abstract][Full Text] [Related]
4. Xeroderma pigmentosum and Cockayne syndrome: overlapping clinical and biochemical phenotypes.
Greenhaw GA; Hebert A; Duke-Woodside ME; Butler IJ; Hecht JT; Cleaver JE; Thomas GH; Horton WA
Am J Hum Genet; 1992 Apr; 50(4):677-89. PubMed ID: 1372469
[TBL] [Abstract][Full Text] [Related]
5. Prenatal diagnosis of xeroderma pigmentosum and Cockayne syndrome.
Cleaver JE; Volpe JP; Charles WC; Thomas GH
Prenat Diagn; 1994 Oct; 14(10):921-8. PubMed ID: 7534923
[TBL] [Abstract][Full Text] [Related]
6. Elevated Urinary Levels of 8-Hydroxy-2'-deoxyguanosine in a Japanese Child of Xeroderma Pigmentosum/Cockayne Syndrome Complex with Infantile Onset of Nephrotic Syndrome.
Kondo D; Noguchi A; Tamura H; Tsuchida S; Takahashi I; Kubota H; Yano T; Oyama C; Sawaishi Y; Moriwaki S; Takahashi T
Tohoku J Exp Med; 2016 Jul; 239(3):231-5. PubMed ID: 27396511
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of a novel missense mutation in the
Stehnach WC; Cantor A; Bongiorno M
BMJ Case Rep; 2023 Oct; 16(10):. PubMed ID: 37848274
[TBL] [Abstract][Full Text] [Related]
8. Cockayne syndrome-xeroderma pigmentosum complex with demyelination: A rare association.
Singh UR; Asif S; Kommu PP; D'Souza P
Indian J Hum Genet; 2012 Jan; 18(1):125-6. PubMed ID: 22754238
[TBL] [Abstract][Full Text] [Related]
9. Two new XPD patients compound heterozygous for the same mutation demonstrate diverse clinical features.
Fujimoto M; Leech SN; Theron T; Mori M; Fawcett H; Botta E; Nozaki Y; Yamagata T; Moriwaki S; Stefanini M; Momoi MY; Nakagawa H; Shuster S; Moss C; Lehmann AR
J Invest Dermatol; 2005 Jul; 125(1):86-92. PubMed ID: 15982307
[TBL] [Abstract][Full Text] [Related]
10. Ocular manifestations of xeroderma pigmentosum: long-term follow-up highlights the role of DNA repair in protection from sun damage.
Brooks BP; Thompson AH; Bishop RJ; Clayton JA; Chan CC; Tsilou ET; Zein WM; Tamura D; Khan SG; Ueda T; Boyle J; Oh KS; Imoto K; Inui H; Moriwaki S; Emmert S; Iliff NT; Bradford P; Digiovanna JJ; Kraemer KH
Ophthalmology; 2013 Jul; 120(7):1324-36. PubMed ID: 23601806
[TBL] [Abstract][Full Text] [Related]
11. Incidence of DNA repair deficiency disorders in western Europe: Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy.
Kleijer WJ; Laugel V; Berneburg M; Nardo T; Fawcett H; Gratchev A; Jaspers NG; Sarasin A; Stefanini M; Lehmann AR
DNA Repair (Amst); 2008 May; 7(5):744-50. PubMed ID: 18329345
[TBL] [Abstract][Full Text] [Related]
12. Xeroderma pigmentosum group E and DDB2, a smaller subunit of damage-specific DNA binding protein: proposed classification of xeroderma pigmentosum, Cockayne syndrome, and ultraviolet-sensitive syndrome.
Itoh T
J Dermatol Sci; 2006 Feb; 41(2):87-96. PubMed ID: 16325378
[TBL] [Abstract][Full Text] [Related]
13. Reduced RNA polymerase II transcription in extracts of cockayne syndrome and xeroderma pigmentosum/Cockayne syndrome cells.
Dianov GL; Houle JF; Iyer N; Bohr VA; Friedberg EC
Nucleic Acids Res; 1997 Sep; 25(18):3636-42. PubMed ID: 9278484
[TBL] [Abstract][Full Text] [Related]
14. Cockayne syndrome complementation group B associated with xeroderma pigmentosum phenotype.
Itoh T; Cleaver JE; Yamaizumi M
Hum Genet; 1996 Feb; 97(2):176-9. PubMed ID: 8566949
[TBL] [Abstract][Full Text] [Related]
15. [Xeroderma pigmentosum and related syndromes].
Berneburg M; Krutmann J
Hautarzt; 2003 Jan; 54(1):33-40. PubMed ID: 12567255
[TBL] [Abstract][Full Text] [Related]
16. Xeroderma pigmentosum/cockayne syndrome complex: first neuropathological study and review of eight other cases.
Lindenbaum Y; Dickson D; Rosenbaum P; Kraemer K; Robbins I; Rapin I
Eur J Paediatr Neurol; 2001; 5(6):225-42. PubMed ID: 11764181
[TBL] [Abstract][Full Text] [Related]
17. Transcription-associated breaks in xeroderma pigmentosum group D cells from patients with combined features of xeroderma pigmentosum and Cockayne syndrome.
Theron T; Fousteri MI; Volker M; Harries LW; Botta E; Stefanini M; Fujimoto M; Andressoo JO; Mitchell J; Jaspers NG; McDaniel LD; Mullenders LH; Lehmann AR
Mol Cell Biol; 2005 Sep; 25(18):8368-78. PubMed ID: 16135823
[TBL] [Abstract][Full Text] [Related]
18. Rare case of Cockayne syndrome with xeroderma pigmentosum.
Bartenjev I; Butina MR; Potocnik M
Acta Derm Venereol; 2000 May; 80(3):213-4. PubMed ID: 10954218
[No Abstract] [Full Text] [Related]
19. Gamma-ray-enhanced reactivation of irradiated adenovirus in Xeroderma pigmentosum and Cockayne syndrome fibroblasts.
Jeeves WP; Rainbow AJ
Radiat Res; 1983 Jun; 94(3):480-98. PubMed ID: 6856785
[TBL] [Abstract][Full Text] [Related]
20. Comparative studies of host-cell reactivation, cellular capacity and enhanced reactivation of herpes simplex virus in normal, xeroderma pigmentosum and Cockayne syndrome fibroblasts.
Ryan DK; Rainbow AJ
Mutat Res; 1986 Jul; 166(1):99-111. PubMed ID: 3014327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
